Drug information for MYAMBUTOL

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET; ORAL 100MG Prescription AB  ETHAMBUTOL HYDROCHLORIDE Ethambutol STI PHARMA LLC 16320
2008-11-07 Label
2008-11-03 Letter
2004-04-05 Label
2004-03-28 Letter
2003-06-10 Label
2003-02-06 Letter
2003-02-06 Letter
2003-02-06 Label
2003-02-06 Label
TABLET; ORAL 200MG Discontinued   ETHAMBUTOL HYDROCHLORIDE Ethambutol STI PHARMA LLC   "
TABLET; ORAL 400MG Prescription AB  ETHAMBUTOL HYDROCHLORIDE Ethambutol STI PHARMA LLC   "
TABLET; ORAL 500MG Discontinued   ETHAMBUTOL HYDROCHLORIDE Ethambutol STI PHARMA LLC   "

Drug Adverse Effects information for MYAMBUTOL

Role code Indications Reaction # Reports
SS CHOLECYSTECTOMY CHOLELITHIASIS 4
SS CHOLECYSTECTOMY CYTOLYTIC HEPATITIS 4
SS CHOLECYSTECTOMY CYTOMEGALOVIRUS INFECTION 4
SS CHOLECYSTECTOMY DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4
SS CHOLECYSTECTOMY EOSINOPHILIA 4
SS CHOLECYSTECTOMY FACE OEDEMA 4
SS CHOLECYSTECTOMY HAEMATEMESIS 4
SS CHOLECYSTECTOMY HAEMOGLOBIN DECREASED 4
SS CHOLECYSTECTOMY ISCHAEMIC STROKE 4
SS CHOLECYSTECTOMY LIPASE INCREASED 4
SS CHOLECYSTECTOMY PROTHROMBIN TIME PROLONGED 4
SS CHOLECYSTECTOMY PRURITUS 4
SS CHOLECYSTECTOMY PULMONARY EMBOLISM 4
SS CHOLECYSTECTOMY RECTAL HAEMORRHAGE 4
SS CHOLECYSTECTOMY RENAL FAILURE 4
SS CHOLECYSTECTOMY SKIN LESION 4
SS GOUT CHOLELITHIASIS 4
SS GOUT CYTOLYTIC HEPATITIS 4
SS GOUT CYTOMEGALOVIRUS INFECTION 4
SS GOUT DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4
SS GOUT EOSINOPHILIA 4
SS GOUT FACE OEDEMA 4
SS GOUT HAEMATEMESIS 4
SS GOUT HAEMOGLOBIN DECREASED 4
SS GOUT ISCHAEMIC STROKE 4
SS GOUT LIPASE INCREASED 4
SS GOUT PROTHROMBIN TIME PROLONGED 4
SS GOUT PRURITUS 4
SS GOUT PULMONARY EMBOLISM 4
SS GOUT RECTAL HAEMORRHAGE 4
SS GOUT RENAL FAILURE 4
SS GOUT SKIN LESION 4
SS LYMPH NODE TUBERCULOSIS ERYTHEMA 5
SS LYMPH NODE TUBERCULOSIS EYELID OEDEMA 5
SS LYMPH NODE TUBERCULOSIS FLUSHING 5
SS LYMPH NODE TUBERCULOSIS LICHENOID KERATOSIS 5
SS LYMPH NODE TUBERCULOSIS PRURITUS 5
SS LYMPH NODE TUBERCULOSIS RASH 5
SS LYMPH NODE TUBERCULOSIS RASH MACULAR 5
SS LYMPH NODE TUBERCULOSIS SKIN EXFOLIATION 5
SS LYMPH NODE TUBERCULOSIS SKIN TOXICITY 5
SS LYMPH NODE TUBERCULOSIS URTICARIA 5
SS PLEUROPERICARDITIS AGITATION 4
SS PLEUROPERICARDITIS ARRHYTHMIA 2
SS PLEUROPERICARDITIS CONFUSIONAL STATE 4
SS PLEUROPERICARDITIS DYSKINESIA 4
SS PLEUROPERICARDITIS SUDDEN DEATH 2
SS PRODUCT USED FOR UNKNOWN INDICATION AGITATION 16
SS PRODUCT USED FOR UNKNOWN INDICATION ARRHYTHMIA 8
SS PRODUCT USED FOR UNKNOWN INDICATION CONFUSIONAL STATE 16
SS PRODUCT USED FOR UNKNOWN INDICATION DYSKINESIA 16
SS PRODUCT USED FOR UNKNOWN INDICATION SUDDEN DEATH 8
SS TUBERCULOSIS CARDIAC FAILURE 4
SS TUBERCULOUS PLEURISY CYTOLYTIC HEPATITIS 2
SS TUBERCULOUS PLEURISY DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2
SS TUBERCULOUS PLEURISY EOSINOPHILIA 2
SS TUBERCULOUS PLEURISY JAUNDICE 2
SS TUBERCULOUS PLEURISY ORAL CANDIDIASIS 2
SS TUBERCULOUS PLEURISY ORAL DISORDER 2
SS TUBERCULOUS PLEURISY PYREXIA 2
SS TUBERCULOUS PLEURISY RASH 2
SS TUBERCULOUS PLEURISY VOMITING 2
C DEPRESSION CYTOLYTIC HEPATITIS 1
C DEPRESSION HEPATOCELLULAR INJURY 1
C DYSLIPIDAEMIA CYTOLYTIC HEPATITIS 2
C HIV INFECTION DEPRESSION 2
C HIV INFECTION ECZEMA 2
C HIV INFECTION HIDRADENITIS 1
C HIV INFECTION LIPODYSTROPHY ACQUIRED 2
C HIV INFECTION LIPOHYPERTROPHY 2
C HIV INFECTION PHARYNGOTONSILLITIS 2
C HIV INFECTION SINUSITIS 2
C HIV INFECTION SUICIDE ATTEMPT 2
C KERATITIS HERPETIC ALTERNARIA INFECTION 4
C KERATITIS HERPETIC CHOLESTASIS 4
C KERATITIS HERPETIC GRANULOMA 4
C KERATITIS HERPETIC HEPATIC FUNCTION ABNORMAL 4
C KERATITIS HERPETIC HEPATOTOXICITY 4
C KERATITIS HERPETIC LUNG DISORDER 4
C KERATITIS HERPETIC MYCOBACTERIUM KANSASII INFECTION 4
C KERATITIS HERPETIC SKIN LESION 4
C KERATITIS HERPETIC TRANSAMINASES INCREASED 4
C MYCOBACTERIUM KANSASII INFECTION ALTERNARIA INFECTION 3
C MYCOBACTERIUM KANSASII INFECTION CHOLESTASIS 3
C MYCOBACTERIUM KANSASII INFECTION GRANULOMA 3
C MYCOBACTERIUM KANSASII INFECTION HEPATIC FUNCTION ABNORMAL 3
C MYCOBACTERIUM KANSASII INFECTION HEPATOTOXICITY 3
C MYCOBACTERIUM KANSASII INFECTION LUNG DISORDER 3
C MYCOBACTERIUM KANSASII INFECTION MYCOBACTERIUM KANSASII INFECTION 3
C MYCOBACTERIUM KANSASII INFECTION SKIN LESION 3
C MYCOBACTERIUM KANSASII INFECTION TRANSAMINASES INCREASED 3
C PRODUCT USED FOR UNKNOWN INDICATION ALTERNARIA INFECTION 6
C PRODUCT USED FOR UNKNOWN INDICATION CHOLESTASIS 6
C PRODUCT USED FOR UNKNOWN INDICATION CYTOLYTIC HEPATITIS 3
C PRODUCT USED FOR UNKNOWN INDICATION GRANULOMA 6
C PRODUCT USED FOR UNKNOWN INDICATION HEPATIC FUNCTION ABNORMAL 6
C PRODUCT USED FOR UNKNOWN INDICATION HEPATOTOXICITY 6
C PRODUCT USED FOR UNKNOWN INDICATION IMMUNE SYSTEM DISORDER 8
C PRODUCT USED FOR UNKNOWN INDICATION LUNG DISORDER 6
C PRODUCT USED FOR UNKNOWN INDICATION LYMPHADENOPATHY 8
C PRODUCT USED FOR UNKNOWN INDICATION MYCOBACTERIUM KANSASII INFECTION 6
C PRODUCT USED FOR UNKNOWN INDICATION SKIN LESION 6
C PRODUCT USED FOR UNKNOWN INDICATION TRANSAMINASES INCREASED 6
C PRODUCT USED FOR UNKNOWN INDICATION TUBERCULOSIS 8
C PULMONARY TUBERCULOSIS CYTOLYTIC HEPATITIS 1
C PULMONARY TUBERCULOSIS HEPATOCELLULAR INJURY 4
C PULMONARY TUBERCULOSIS PERIARTHRITIS 3
C RHEUMATOID ARTHRITIS IMMUNE SYSTEM DISORDER 2
C RHEUMATOID ARTHRITIS LYMPHADENOPATHY 2
C RHEUMATOID ARTHRITIS TUBERCULOSIS 2
Ads by Google